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Abstract
It is well known that angiogenesis is linked to fibrotic processes in fibroproliferative diseases, but 
insights into pathophysiological processes are limited, due to lack of understanding of molecular 
mechanisms controlling endothelial and fibroblastic homeostasis. We demonstrate here that the 
matrix receptor anthrax toxin receptor 1 (ANTXR1), also known as tumor endothelial marker 8 
(TEM8), is an essential component of these mechanisms. Loss of TEM8 function in mice causes 
reduced synthesis of endothelial basement membrane components and hyperproliferative and 
leaky blood vessels in skin. In addition, endothelial cell alterations in mutants are almost identical 
to those of endothelial cells in infantile hemangioma lesions, including activated VEGF receptor 
signaling in endothelial cells, increased expression of the downstream targets VEGF and 
CXCL12, and increased numbers of macrophages and mast cells. In contrast, loss of TEM8 in 
fibroblasts leads to increased rates of synthesis of fiber-forming collagens, resulting in progressive 
fibrosis in skin and other organs. Compromised interactions between TEM8-deficient endothelial 
and fibroblastic cells cause dramatic reduction in the activity of the matrix-degrading enzyme 
MMP2. In addition to insights into mechanisms of connective tissue homeostasis, our data provide 
molecular explanations for vascular and connective tissue abnormalities in GAPO syndrome, 
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caused by loss-of-function mutations in ANTXR1. Furthermore, the loss of MMP2 activity 
suggests that fibrotic skin abnormalities in GAPO syndrome are, in part, the consequence of 
pathophysiological mechanisms underlying syndromes (NAO, Torg and Winchester) with 
multicentric skin nodulosis and osteolysis caused by homozygous loss-of-function mutations in 
MMP2.
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Introduction
Dysregulation of fibrous connective tissues in fibroproliferative diseases is a leading cause 
of morbidity and mortality in developed countries with about 45% of deaths attributed to 
such disorders [1]. Alterations in vascular remodeling and angiogenesis are associated with 
fibrotic processes in different organs [2–5], and systemic sclerosis is correlated with 
progressive disappearance of blood vessels in the skin [6]. Recently, it has been reported 
that high levels of vascular endothelial growth factor A (VEGF) aggravates fibrosis in 
experimental animal models and stimulates collagen production by cultured fibro-blasts 
isolated from the skin of systemic sclerosis patients [7]. Understanding how such VEGF 
activities can be reconciled with the disappearance of skin blood vessels during progression 
of fibrosis in vivo, is problematic without deeper insights into molecular mechanisms 
responsible for regulating interactions between endothelial and fibroblastic cells, 
inflammatory cells and macrophages in physiological connective tissue homeostasis.
For several reasons, studies of the receptor ANTXR1 [8–11], also known as TEM8 [12]; are 
likely to provide such insights. In vitro data suggest that TEM8 has a role in adhesion, 
spreading and migration of cells through its interaction with extracellular matrix (ECM) 
components [13–16]. Expression in different cell types and the existence of at least 5 
different splice variants, both with and without transmembrane domains, suggests flexible 
regulatory functions in different tissues [17]. Abnormal clustering of TEM8 with integrin β1 
and vascular endothelial growth factor receptor 2 (VEGFR2) occurs in endothelial cells with 
in cutaneous infantile hemangiomas, the most common vascular anomaly in childhood. 
Appearing soon after birth, hemangiomas grow rapidly for a few months. This is followed 
by a period of involution and replacement of the endothelium by fibro-fatty tissue, 
sometimes leaving disfiguring scars. Finally, in patients with the recessive GAPO syndrome, 
loss-of-function mutations in TEM8 result ingrowth retardation and bone defects in addition 
to hemangioma-like vascular anomalies in skin and progressive fibrosis of several organs, 
including skin [18].
Hemangiomas are discrete lesions and the cutaneous changes in GAPO syndrome are 
systemic in nature. However, the similarities between the vascular and connective tissue 
defects in the two disorders suggest that the responsible molecular mechanisms have 
common features that are relevant to the regulation of connective tissue homeostasis. To 
identify the cellular and molecular mechanisms by which TEM8 functions in both vascular 
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and connective tissues in vivo, we generated and studied Antxr1 null mice as well as mice 
with conditional deletion of Antxr1 in endothelial cells. In addition, we generated mice that 
are heterozygous for an Ala-to-Thr substitution in the transmembrane domain of TEM8, 
previously identified in a hemangioma patient as a heterozygous germ-line mutation in 
TEM8 variants 1, 2 and 4 [17,19]. The results of these studies show for the first time that 
although TEM8-deficient mice do not have localized vascular hemangiomas, they develop 
proliferative vessels in skin with cell signaling alterations and cellular changes, such as 
invasion of macrophages and mast cells that are identical to those seen in human 
hemangioma lesions. In addition, TEM8-deficient mice exhibit progressive skin fibrosis 
with increased synthesis of collagens in fibroblasts, contrasted with reduced synthesis of 
major components of vascular basement membranes. Knock-in mice, carrying the Ala-to-
Thr substitution in TEM8, show skin defects consistent with the conclusion that the 
mutation has a dominant negative effect on TEM8 function. Loss of TEM8 function is also 
associated with compromised interactions between TEM8-deficient endothelial and 
fibroblastic cells, resulting in a dramatic reduction of matrix metalloproteinase-2 (MMP2) 
activity. Our study provides a mechanistic explanation for skin and vascular abnormalities in 
GAPO syndrome [20–22] and suggests that fibrotic skin abnormalities in GAPO syndrome 
are, in part, the consequence of pathophysiological mechanisms underlying syndromes with 
multicentric skin nodulosis and osteolysis caused by homozygous loss-of-function mutations 
in MMP2 [23–25]. Most importantly, the data demonstrate that TEM8 is an essential 
regulator of connective tissue homeostasis. TEM8 controls synthesis of major matrix 
components in both endothelial and fibroblastic cells, it regulates signaling pathways 
controlling growth factors and chemokines, and it is an essential component of an 
endothelial-fibroblastic interaction mechanism for control of matrix degradation.
Results
Loss of TEM8 causes embryonic and postnatal vascular and connective tissue defects
Antxr1 null mice, expressing LacZ for localizing Antxr1 promoter activity, were generated 
as described in the Methods section. At embryonic days E9.5– E11.5, limb buds, cranial 
primary vessels, perioptic vascular plexus, cardinal and umbilical veins showed β-
galactosidase activity (not shown). At E13.5–14.5 LacZ staining of Antxr1−/− whole mount 
embryos showed strong promoter activity (Figs. 1a and S1b). The perichondrium of all 
cartilaginous primordia, vibrissae and arteries, including aorta were strongly positive. 
Extensive hemorrhage found in many Antxr1−/− embryos at E11.5 suggested that mutants 
have defective and leaky vessels (Fig. 1b). Newborn mutant pups did not exhibit any major 
defects by gross inspection, but homozygous mutants were slightly smaller than 
heterozygotes and wild-type controls. Homozygous mutants showed progressive growth 
retardation, bone loss, a shortened skull with frontal bossing and midfacial hypoplasia (Fig. 
1c). At 4– 21 weeks, mutant mice had significantly lower body weight than their control 
littermates (Fig. 1d). Furthermore, Antxr1 null animals exhibited increased ECM deposition, 
including fibrosis of various organs and skin (Fig. S1c). Heterozygous knock-in mice, 
carrying the A-to-T missense change in TEM8, also exhibited growth retardation (Fig. 1e) 
and increased ECM deposition in skin (Fig. S1d). This is consistent with previous studies 
indicating that the mutation has a dominant negative effect on TEM8 function [26].
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Blood vessel defects and cell signaling alterations in Antxr1−/− skin are similar to those in 
human infantile hemangiomas
In the skin of Antxr1−/− animals, intense LacZ activity was found in vessel layers (Fig. 2a). 
At week 7, these layers contained increased numbers of dilated and leaky vessels as shown 
by extravasation of perfused FITC-coupled dextran (Fig. 2b). Staining of endothelial cells 
with lectin showed discontinuous staining with reduced intensity (Fig. 2c). Reduced staining 
with antibodies against calponin indicated impaired vessel coverage by perivascular cells 
(Fig. 2c). Similar changes were present but less severe in heterozygous animals. Skin vessels 
in Antxr1−/−animals exhibited increased endothelial cell proliferation and perivascular cell 
apoptosis. BrdU-labeling indicated greater than 4-fold increase in proliferation of CD31-
positive cells and increased numbers of TUNEL-positive CD31-negative cells (Figs. 2d and 
S2a–c, e–f). A substantial increase in BrdU-labeling was also found in skin from 
heterozygous knock-in mice (Fig. S2d).
Decreased levels of VEGFR1 and β1 integrin transcripts were found in skin lysates of 
Antxr1−/−mice (7 weeks) by RT-PCR (Fig. 3a). A 3-fold increase in Vegfa transcripts, but 
no changes in other VEGF isoforms, was associated with a 2-fold increase in VEGF plasma 
levels in Antxr1−/− mice (Fig. 3a) and with increased VEGFR2 signaling. Results of 
western blotting demonstrated that levels of VEGFR1 were decreased, while levels of 
VEGFR2, phosphorylated VEGFR2, VEGFA and Hif-1α, a downstream target of VEGFR2 
signaling, were increased (Fig. 3b). Increased levels of phosphorylated Tie-2 and 
Angiopoietin 2 indicated that Tie-2 signaling was also affected (Fig. 3b).
Immunohistochemistry showed increased levels of phospho-Erk1/2, indicating that Erk1/2, a 
downstream effector of VEGFR2 signaling, was activated in mutant vascular cells (Fig. 3c). 
In addition, examination of skin lysates of Antxr1−/− mice (7 weeks) by RT-PCR and 
ELISA showed increased transcript and protein levels of the Hif-1α target, CXCL12/
SDF-1α, increased levels of transcripts for its receptor Cxcr4, and increased plasma levels of 
CXCL12 in Antxr1−/−mice compared with WT controls (Fig. 3d). Skin lysates of 
heterozygous knock-in mice had similar increases in transcript levels for Vegfa, Cxcl12 and 
Cxcr4 and increased protein levels of CXCL12 (Fig. 3e).
Loss of TEM8 results in dramatic changes in synthesis of extracellular matrix components 
in skin and other organs
Analyses of RNA isolated from the skin of 7-week old mice revealed increased transcript 
levels for collagens type I (Col1a1) and type VI (Col6a1, Col6a3, Col6a5, and Col6a6), but 
reduced levels in the case of Col4a1, Col18a1 and lama5 genes (Fig. 4a). Western blots of 
total skin lysates showed increased levels of collagen VI and decreased levels of collagen IV 
(Fig. S3a). Mutant skin sections showed increased staining for collagen I. The staining was 
predominant in the dermis and especially strong around the hair bulbs and dermal papillae 
(Fig. 4b). The cutaneous vascular layer of mutant skin showed reduced staining for α1 
(XVIII) collagen chains (Fig. S3b). In contrast, collagen VI staining was very strong in the 
same area (Fig. 4c). Blood vessel walls in mutant skin appeared to be thickened in PAS-
stained sections and PAS-stained material was observed in congested vessels (Fig. S3c). 
Patchy loss of vascular basement membranes and accumulation of collagen fibrils between 
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endothelial and perivascular cells in mutant skin were observed by electron microscopy 
(Figs. 4d and S3d).
To determine whether the increased accumulation of collagen in mutant skin may be the 
result of increased synthesis of collagen in fibroblastic cells, we isolated skin fibroblasts 
from E17.5 Antxr1+/+ and littermate Antxr1−/− embryos and compared their incorporation 
of L-[14C(U)]-Proline into collagen in culture. The results demonstrated a 2-fold increase in 
the rate of collagen accumulation both in the medium and the cell layer, consistent with 
increased amounts of pepsin-extracted material from skin of 7-week and 3-month old 
Antxr1−/− mice and increased amounts of α1(I) and α2(I) collagen chains (as determined by 
gel electrophoresis and mass spectrometry (Figs. 4e,f and S3e)). Dramatic changes in skin 
morphology, including reduced cellularity, degenerated hair follicles, and increased 
accumulation of acellular extracellular matrix, were observed in sections from Antxr1−/
−mutants at 12 weeks (Fig. S3f).
These findings indicate that vascular changes in mutant skin are early (7 weeks) events that 
are followed by an increasingly severe skin fibrosis over time (12 weeks).To examine the 
potential contribution of vascular changes to the fibrosis, we examined mice with 
conditional deletion of Antxr1 in vascular endothelial cells. The severe skin fibrosis and 
increased expression of collagens α1(I) and α1(VI) in these conditional mutants clearly 
indicate that changes in endothelial cells are important parts of the fibrotic mechanism (Fig. 
5a, b). Monocytes, macrophages and mast cells are known to play a role in the pathogenesis 
of fibrosis by secreting profibrotic mediators, such as IL-1, −4, −6, −8, TNF-α, CTGF and 
TGF-β. Consistent with the increased levels of CXCL12 in mutant animals (Fig. 3d, e), the 
number of macrophages and mast cells was substantially increased in skin of Antxr1−/− 
mice (Fig. 5c, d). This was associated with increased numbers of interstitial collagen-
producing cells, as shown by immunostaining for FSP1, a marker for cells engaged in 
fibrogenesis (Fig. 5e).
Dysregulated extracellular matrix proteolysis in skin of mutant mice
The data described above indicate that increased synthesis of fibrillar collagen matrix is a 
major contributor to the fibrosis in TEM8-deficient mice. However, they do not exclude the 
possibility that the rate of matrix degradation may also be affected. Balance of matrix 
production with degradation is critical for normal angiogenesis and connective tissue 
homeostasis. RNA analyses did not show statistically significant differences in transcript 
levels of the matrix metalloproteinases Mmp2 and Mmp9 in the skin of control and mutant 
animals (Fig. 6a), but immunoblotting revealed increased protein levels of both proteins in 
mutant skin lysates (Fig. 6b). Immunostaining for MMP9 showed the enzyme to be 
expressed in the stratum basale of epidermis, the bulge region of hair follicles, sebaceous 
glands, and in interstitial/dermal cells with monocyte–macrophage morphology (Fig. S4a). 
MMP2 protein was detected primarily in vascular beds in skin (Fig. S4b). Surprisingly, 
while the protein level of MMP2 in skin lysates was increased, its activity was dramatically 
reduced both in Antxr1−/− mice and in Antxr1fl/fl::Cdh5Cre mice (Figs. 6c, d and S5a). In 
contrast, the level of active MMP14 was increased (Fig. 6c). RNA analyses indicated that 
Timp2 and Timp3 transcript levels were decreased while Timp1 transcripts were not changed 
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(Fig. 6e). Given the positive role of TIMP2 in MMP14-dependent activation of MMP2, it is 
possible that the low levels of Timp2 expression may contribute to the lack of MMP2 
activity in Antxr1−/− skin. However, it is unlikely to be a major factor since MMP2 activity 
levels were reduced by only 30% in skin lysates of Timp2−/− mice (Fig. 6d).
Loss of MMP2 activity requires loss of TEM8 function in both endothelial and fibroblastic 
cells
Substantial fibrosis, but only about 40% loss of MMP2 activity in mice with conditional 
deletion of Antxr1 in endothelial cells, suggests that the almost complete loss of MMP2 
activity in skin of Antxr1−/−mice requires loss of TEM8 function in both endothelial and 
non-endothelial cells. To examine the contributions of endothelial and fibroblastic non-
endothelial cells to the overall reduction in MMP2 activity, we used three approaches. First, 
we generated three stable human dermal microvascular endothelial cell (HDMEC) lines with 
different levels of TEM8 knockdown. The three lines, shTEM8-1, shTEM8-2 and 
shTEM8-3, had 26%,60% and 90% knockdown of TEM8, respectively (Fig. S5b). The level 
of TEM8 knockdown correlated with the degree of increase in VEGF levels, both in total 
cell lysates and in conditioned media (Figs. 7a and S5c). Reducing TEM8 expression 
resulted in up to 30% reduction of MMP2 activity in lysates of the endothelial cell lines 
(Figs. 7b and S5d).
Second, we measured the activity of MMP2 in fibroblasts. No difference in the activity of 
MMP2 was found between WT and mutant fibroblasts isolated from either E17.5 mouse 
embryos or from the skin of adult mice (data not shown). Third, we assayed for MMP2 
activity in an endothelial-fibroblast co-culture system. Co-culture of the human shTEM8-2 
or shTEM8-3 endothelial cells with fibroblasts isolated from the skin of adult Antxr1−/− 
mice resulted in dramatic reduction of enzyme activity (Figs. 7c and S5e). Importantly, the 
level of reduction of MMP2 activity strongly depended on the level of TEM8 knockdown in 
endothelial cells; no changes in MMP2 enzymatic activity compared with control shTEM8 
cells were observed when shTEM8-1 (26% TEM8 knockdown) endothelial cells were co-
cultured with murine Antxr1−/− or Antxr1+/+ fibroblasts (data not shown).
To examine the mechanism by which TEM8-dependent endothelial cell-fibroblast 
communication results in inactivation of MMP2, we isolated primary CD31-positive 
(CD31+) and CD31-negative (CD31−) cells in one step from the same sections of mouse 
skin tissue of 7-week old WT control and Antxr1−/− mutant littermates (Fig. S5f). RNA 
analyses showed that expression levels of Col1a1 were six-fold higher in control CD31− 
than in control CD31+ cells and fivefold higher in mutant than in control CD31− cells (data 
not shown), suggesting that the CD31− cell population represents collagen I-expressing 
fibroblastic cells. No changes in MMP2 gelatinolytic enzyme activity were observed when 
WT CD31+ cells were co-cultured with either Antxr1−/− or WT CD31− cells. However, co-
cultivation of mutant CD31+ and mutant CD31−cells led to substantial loss of gelatinase 
activity, whereas co-cultivation of mutant CD31+ cells with WT CD31-negative cells had 
little effect (Figs. 7d and S5g). To examine whether the effect on MMP2 activation requires 
cell–cell contact or is due to paracrine signaling, endothelial CD31+ and fibroblastic CD31− 
cells were incubated in fibroblast (CD31−) or endothelial (CD31+) cell-conditioned medium 
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(FCM and ECM, respectively). The MMP2 activity was not affected when WT or mutant 
CD31− cells were treated with ECM from WT or mutant CD31+ cells or when WT CD31+ 
cells were treated with FCM from CD31− cells. However, the activity was dramatically 
reduced when mutant CD31+ cells were treated with mutant FCM (Figs. 7d and S5g). 
Finally, western blotting of total skin lysates as well as lysates of co-cultures of mutant 
CD31+ and mutant CD31− cells showed substantial reduction in the level of active (cleaved) 
form of ADAM17 (Fig. S5h). Since it has been reported that ADAM17 activity is necessary 
for VEGF-induced MMP-2 activation [27], it is possible that a loss of its activity may 
contribute to the loss of MMP2 activation.
Experiments in which transcript levels of Col1a1, Col6a1 and Fn1 were measured in WT 
and Antxr1−/− fibroblasts cultured in conditioned media of CD31+ cells indicated that 
increased expression of the three matrix genes is primarily a consequence of loss of TEM8 
function in fibroblasts (Fig. S5i). Tnfa and Ctgf expression levels were also increased (data 
not shown). Taken together, the data indicate that TEM8 functions in both endothelial cells 
and fibroblasts to control matrix homeostasis and that increased accumulation of 
extracellular matrix in TEM8-deficient skin is the result of increased synthesis in 
fibroblastic cells and decreased degradation mediated by MMP2.
Discussion
Vascular and connective tissue homeostasis is maintained by cell–cell and cell–ECM 
interactions. In vitro and in vivo studies have suggested that ANTXR1/TEM8 may play a 
role in these interactions [17,28–33]. However, insights into the mechanisms involved have 
been lacking. For example, in endothelial cells of rapidly growing infantile hemangiomas, 
clustering of TEM8 with VEGFR2 and β1 integrin is associated with a decrease in VEGFR1 
expression and activation of VEGFR2 signaling [26]. Based on the similarities between 
signaling changes in the skin of TEM8-deficient mice and in endothelial cells isolated from 
infantile hemangioma patients [26], including a case with the heterozygous TEM8 Ala-to-
Thr missense mutation that was knocked into mice as described here, we conclude that 
TEM8 is essential for regulation of VEGF receptor signaling in vascular endothelial cells. 
The vascular skin abnormalities in Antxr1−/− mice, and presumably in GAPO syndrome 
patients [30], are not localized as in the lesion of an infantile hemangioma, but are clearly, 
on a systemic level, reproducing what happens within hemangiomas during their 
proliferative phase; reduced synthesis of basement membrane components, activation of 
VEGFR2 signaling associated with low levels of VEGFR1 and increased levels of Hif-1α 
and its downstream targets CXCL12 and VEGF [34]. As a result, increased numbers of 
macrophages and mast cells are recruited into the vascular area, both in the skin of Antxr1−/
− mice and within hemangioma lesions [35]. In turn, this is likely contributing to increased 
levels of TGF-β1 and CTGF, with the latter being a direct target of Hif-1α as well as a 
downstream effector of TGF-β1 profibrotic activity [36,37].
The detailed and specific roles of these cellular changes and cytokines during the involution 
of hemangiomas when the endothelial cells undergo apoptosis and are replaced by fibro-
fatty tissue, need further studies. However, our data indicate that the loss of TEM8 function, 
even when limited to VE-cadherin-expressing cells, results in the production of 
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profibrogenic growth factors that are capable of stimulating fibroblast activation and 
collagen production. Such effects, likely mediated by macrophages and mast cells, may 
contribute to the tissue changes associated with hemangioma involution.
The extracellular matrix changes in the skin of the Antxr1−/− mice also provide a 
mechanistic explanation for the progressive accumulation of extracellular matrix in 
individuals with the GAPO syndrome [38]. Increased synthesis of matrix proteins, such as 
fibronectin and collagen types I and VI, is a direct consequence of the lack of TEM8 
function in fibroblasts. In addition, our data demonstrate that the breakdown of matrix is 
compromised in the skin of knockout animals. In spite of increased levels of MMP2 protein 
and the mature active form of MMP14, increased Ctgf expression and reduced expression of 
Timp2 in Antxr1−/− mice, the proteolytic activity of MMP2 is substantially repressed. 
Previous studies indicated that CTGF enhances the activation of MMP-2 through an effect 
on MMP2 protein expression and suppression of TIMP2 [39]. However, it has also been 
shown that increased levels of fibronectin, as in the case of TEM8-deficient fibroblasts 
described here, suppress the effect of CTGF on MMP2 activation [40]. It is also well 
established that TIMP2 is critical for MMP14-dependent activation of pro-MMP2 by serving 
as an adapter molecule in the MMP2/MMP14/TIMP2 complex [41–45], and we show here 
that MMP2 activity is reduced in the skin of Timp2−/− mice to the same extent as the 
reduction of activity in the skin of animals with conditional deletion of Antxr1 in Cadh5Cre-
expressing cells. Although MMP2 protein is primarily expressed in the vascular region of 
the skin in Antxr1−/− mice, our data indicate that the loss of TEM8 function in both vascular 
endothelial and fibroblastic cells contribute to the loss of MMP2 activity. First, partial 
reduction of MMP2 activation occurs when TEM8 levels in endothelial cells are knocked 
down. Second, MMP2 activity is practically eliminated when Antxr1−/− endothelial cells are 
exposed to conditioned media from Antxr1−/− fibroblastic cultures. Importantly, this 
reduction in activity only occurs when Antxr1−/− endothelial cells are exposed to 
conditioned media from Antxr1−/− non-endothelial (fibroblastic) cells; conditioned media 
from control non-endothelial cells has no effect on MMP2 activity. In addition, no 
differences in MMP2 activity were observed between lysates of wild type and Antxr1−/− 
fibroblasts. Based on these findings, we hypothesize that fibroblastic Antxr1−/− cells secrete 
a factor that blocks activation of MMP2 produced by endothelial cells. Importantly, this 
blocking effect is only seen when endothelial cells are TEM8-deficient, suggesting that 
TEM8 is a regulator of co-operative processes between endothelial and fibroblastic cells. 
Further studies are required to identify the factors involved. However, studies demonstrating 
that extracellular Prostate apoptosis response-4 (Par-4) protein is an inhibitor of MMP2 
gelatinase activity and that phosphorylation of MMP2 inhibits its activity, suggest that 
different kinds of inhibitory factors need to be considered [46–48].
The almost complete loss of MMP2 proteolytic activity in the skin of Antxr1−/− mice 
indicates that some of the skin lesions in GAPO syndrome patients are the consequences of 
pathophysiological mechanisms similar to those that are responsible for skin lesions in a 
group of osteolysis syndromes (NAO, Torg and Winchester) caused by compound 
heterozygous or homozygous loss-of-function mutations in MMP2 [23–25]. Local or more 
widespread accumulation of extracellular matrix components is a characteristic of all the 
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syndromes, albeit to various degrees. The clinical differences may reflect differences in the 
involvement of other pathways. For example, since MMP2 activates TGF-β1 by cleaving the 
latency-associated peptide, the loss of MMP2 activity alone is likely to result in reduced 
levels of TGF-β1 [49,50]. However, the level of TGF-β1 in skin lysates of Antxr1−/− mice is 
increased and this may contribute to the severe progressive fibrosis in the animals and 
presumably in GAPO syndrome patients. Whether the skeletal changes in GAPO patients 
are the consequences of mechanisms similar to those responsible for osteolysis in patients 
with NAO, Torg and Winchester syndromes, is a question that can only be addressed by 
further studies of skeletal changes in Antxr1−/− mice.
Methods
Generation of Antxr1 null mice
Generation of null mice (Antxr1tm1(KOMP)Vlcg) was done through the service provided by the 
trans-NIH Knock-Out Mouse Project (KOMP); project ID is VG10072. Deletion of 29,703 
bases of chromosome 6 (deletion starting at 87, 262, 372 position and ending at position 87, 
232,670) results in a frameshift deletion of seven exons (from 2 through 8) and generates a 
premature stop codon that eliminates synthesis of all ANTXR1/TEM8 transcript variants. 
Exon 1 in the null allele was replaced by a TM-LacZ reporter cassette under the control of 
Antxr1 regulatory sequences, allowing spatial and temporal visualization of the pattern of 
Antxr1 deletion. Mutant mice were generated using the C57BL6/NTac strain and 
subsequently crossed into the C57BL6/J strain. Crosses between heterozygous Antxr1+/- 
mice produced progeny of 21% Antxr1+/+, 56% Antxr1+/- and 23% Antxr1−/− pups in 100 
analyzed litters. At 4–5 months, the mortality rate of Antxr1−/− mice was 35%. In addition, 
female homozygous knockout mice were infertile and males exhibited impaired 
reproductive function after 2–3 months. Malocclusion was found in 25% of the 
homozygotes after 3 months of age.
Generation of Antxr1 KI mice
Anthrax1 [Mus musculus, Gene ID: NM_054041] gene targeting vector containing the point 
mutation A324T(GCT/ACT) and fusion of exons E12 and E13 (Fig. S1e), was constructed 
by Applied StemCell, Inc. and electroporated into a hybrid mouse embryonic stem cell 
(ESC) line (C57BL6/129SvJ; #ASE-9005).
The neomycin cassette flanked by FRT sites was used as a positive selection marker, while 
the Diphtheria toxin A fragment cassette (DTA) served as a negative selection marker.
Both 5′ arm and 3′ arm of the targeting vector were designed as homologous arms to introns 
flanking the E12 and E13, to facilitate homologous recombination. Sequence data were 
obtained using primer T-SQ1. Sequencing alignment was carried out against that of Antxr1 
vector construct to confirm the deletion of the intron between Exon12 and Exon13, as well 
as the incorporation of point mutation in Exon13 on the targeted allele (Fig. S1e).
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Other mouse lines used
Antxr1 floxed, Cdh5Cre (B6.Cg-Tg(Cdh5-cre)7Mlia/J, Jackson Laboratory) and Timp2 null 
mouse lines have been described previously [28,45].
Histology
Dorsal skin samples from 7 week- and 3 month-old Antxr1−/− mice and control littermates 
were collected, fixed overnight in 4% PFA (VWR Int.) at 4 °C and either dehydrated 
through a graded ethanol series or immersed in 30% sucrose/PBS solution for 24 h at 4 °C 
prior to paraffin or OCT (Sakura Finetek, USA Int.) embedding and sectioning. For 
histological examination H&E and Masson’s Trichrome staining was used on 5 µm thick 
sections according to standard protocols. Toluidine blue, pH = 2.2, was used for staining of 
mast cells.
Western blotting
Western blots were carried out using Abcam western blot protocols. Bullet Blender 
(BBX24, Next Advance Inc.) and corresponding kit (9–2.0 mm stainless steel bead blend, 
product number SSB14B and 3.2 mm stainless steel balls in Screw-Cap RINO tubes) were 
used for homogenization of skin samples. Briefly, lysates were prepared by adding 0.5 ml of 
pre-chilled (4 °C) M-PER® lysis buffer (mammalian protein extraction buffer, Thermo 
Scientific) supplemented with proteinase (Roche Applied Science) and phosphatase (Roche 
Applied Science) inhibitor cocktails to 50–100 mg of frozen tissue and placed in bullet 
blender lysis kit tubes. For in vitro and ex vivo cell culture analysis, cell lysates were 
collected using M-PER® buffer supplemented with protease and phosphatase inhibitor 
cocktail (Roche Applied-Science). After centrifugation, homogenates were transferred to 
new tubes and left on ice for 30 min before spinning for 30 min at 12,000 rpm in a 4 °C pre-
cooled centrifuge. After spinning, supernatants were transferred to fresh tubes kept on ice. 
Bradford assay (Thermo Scientific) was used to determine protein concentration. Tissue 
lysates were stored at −80 °C. Lysates containing 10–30 µg of protein were electrophoresed 
using 5%, 10% or 16% SDS-bispolyacrylamide gels and separated proteins in the gels were 
transferred to nitrocellulose membranes. After 1 hour blocking at room temperature in 5% 
milk/TBST (1× PBS, 0.2% Tween-20), blots were incubated overnight at 4 °C with primary 
antibodies diluted in 4% BSA (Sigma Aldrich)/TBST solution. After washing 3 times for 5 
min in TBST, blots were incubated with secondary antibodies for 1 h at room temperature 
and immunoreactive bands were visualized by chemiluminescent substrate (Thermo 
Scientific). Secondary antibodies, anti-mouse HRP (1:1000, #32430, Thermo Scientific), 
anti-rabbit HRP (1:10,000, #31460, Thermo Scientific) and anti-goat HRP (1:5000, sc-2056, 
Santa Cruz) were diluted in 5% milk/TBST solution. The following primary antibodies were 
used for western blotting: Flk1 (1:1000, sc-504, Santa Cruz), p-Flk1 (1:1000, sc-101820, 
Santa Cruz), Flt1 (1:1000, sc-316, Santa Cruz), phospho-VEGFR1 (1:1000, ab62183, 
Abcam) Tie2 (1:1000, sc-324, Santa Cruz), phospho-Tie2 (1:1.000, ABS219, Millipore), 
VEGF-A (1:500, sc-152, Santa Crus), p44/42 ERK1/2 (1:1000, #9194, Cell Signaling), 
phospho-p44/42-ERK1/2 (1:1000, #9101, Cell signaling), S100A4 (1:1000, ab27957, 
Abcam), α-SMA (1:1000, ab5694, Abcam), Ang1 (1:500, sc-6319 Santa Cruz), Ang2 
(1:500, sc-7015, Santa Cruz), MMP2 (1:1000, ab37150, Abcam), MMP14 (1:1000, 
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GWB-171BC8, GenWay Biotechnology Incorporation), MMP9 (1:1000, AF909, R&D 
Systems), β-actin (1:5000, A5441, Sigma Aldrich), and CD31 (1:1000, ab28364, Abcam).
Gelatin zymography
For gelatin zymography tissue or cell lysates were mixed with 6× SDS loading buffer (375 
mM Tris–HCl pH 6.8, 6% SDS, 48% glycerol, and 0.03% bromophenol blue) without the 
addition of reducing reagents and boiling; aliquots containing 10 µg of total protein were 
loaded on 10% bis-acrylamide resolving gel copolymerized with 0.1% of gelatin. After 
electrophoresis, gels were washed in zymogram renaturing buffer containing 2.5% of Triton 
X-100 for 2 h and incubated for 24 h (37 °C) in enzyme developing buffer (50 mM of Tris–
HCl, pH 7.4; 10 mM of CaCl2; 150 mM of NaCl; 1 µM of ZnCl2 and 0.01% of NaN3). 
Staining of gels was done in Coomassie brilliant blue R-250 staining solution (0.5% R-250, 
30% methanol and 10% acetic acid) for 2 h followed by the gel distaining procedure. 
Gelatinolytic bands were quantified with Image J software (http://imagej.nih.gov).
Quantitative real-time PCR
Total RNA was isolated and first strand cDNA was synthesized using iScript (Bio-Rad). 
Quantitative real-time PCR with a BioRad iCycler® used primers mixed with the 
iQ™SYBR®Green Supermix (Bio-Rad). Primer sets for Vegfr1, Vegfr2, Tie2, Itg1, Vegf-
variants, Mmp2, Mmp9, Timp1, Timp2, Timp3, Col1a1, Col6a5, Col6a3, Col6a1/2, 
Col18a1, Col4a1, Lama5 and Gapdh were purchased from Invitrogen. Primers are listed in 
Supplementary Table 1. Specificity of reactions was determined by melting curve analysis. 
The relative fold changes of gene expression between each gene of interest were calculated 
by standard curve method. For each gene of interest ≥3 independent experiments were 
performed and each experiment was run in duplicates or triplicates.
ELISA assays
VEGF and CXCL12/SDF-1 protein levels in tissue, plasma, cell lysates and conditional cell 
medium were assessed using the Quantikine Mouse VEGF- and SDF-1 Immunoassays 
(R&D Systems) in accordance with the manufacturer’s instructions; VEGF and SDF-1 
levels in tissue lysates and in lysates from confluent cultures were normalized to protein 
levels. The optical density of each well was determined using a microplate reader set to 450 
nm.
Immunofluorescence
Paraffin or frozen 5 µm sections of skin tissue samples were stained with the following 
antibodies: CD31 antibody (1:100, ab28364 Abcam) for detection of endothelial cells; 
Calponin (1:100, EP798Y, Abcam) and α-SMA (1:200, ab5694, Abcam) for detection of 
perivascular cells, and F4/80 (1:100, ab6640, Abcam) for assessing macrophages in vivo. 
Collagen type I (1:200, ab21286, Abcam), collagen type IV (1:100, AB756, Chemicon), 
collagen type XVIII (1:100, sc-32720, Santa Cruz), collagen type VI (1:50, sc-167530, 
Santa Cruz), and fibronectin (1:500, sc-9068, Santa Cruz) were used for extracellular matrix 
and basement membrane evaluation. Incubation with primary antibody was followed by 
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FITC or Texas Red labeled secondary antibody (1:500, Vector Laboratories). Nuclei were 
stained with Hoechst 33342 fluorescent dye (Thermo Scientific).
FITC-Dextran and FITC-Lycopersicon esculentum lectin perfusion
Fluorescein isothiocyanate–dextran (FITC conjugated Dextran, Sigma-Aldrich, FD150) and 
FITC-L. esculentum lectin (Vector Laboratories) were used to assess vessel leakage/integrity 
according to established protocols. Briefly, after induction of anesthesia the chest cavity of 
mice was opened, a needle was inserted into the right heart ventricle to allow outflow of 
blood, and a perfusion cannula was inserted into the left ventricle. The mice were first 
perfused with PBS, pH 7.4, to wash out erythrocytes, and this was followed by fixative 
solution containing 1% paraformaldehyde and 0.5% glutar-aldehyde in PBS. The perfusion 
was followed by 20 µg/ml (FITC)-coupled Dextran or 10 µg/ml FITC-conjugated L. 
esculentum lectin in 1% of Bovine Serum Albumin (BSA, Sigma-Aldrich) in PBS. A 
perfusion with blocking solution, 3% BSA in PBS was used prior to lectin infusion. Isolated 
skin tissue samples were post-fixed over night at 4 °C in PFA before being saturated in 
phosphate-buffered 30% sucrose solution.
Colorimetric immunohistochemistry
Immunohistochemistry with the Vector®NovaRed™ Substrate kit (Vector laboratories Inc.) 
and VESTASTAIN®Elite ABC kit (Vector laboratories Inc.) was performed according to 
the manufacturer’s instructions. Paraffin or frozen 5 µm sections of skin tissue samples were 
stained with the following antibodies: Phospho- p44/42-ERK (1:100, #9101, Cell signaling), 
S100A4 (1:500, ab27957, Abcam), MMP2 (1:100, ab37150, Abcam) and MMP9 (1:100, 
AF909, R&D Systems).
Whole-mount and section staining for β-galactosidase activity
After fixation of mutant and control E13.5 embryos in 0.2% glutaraldehyde in PBS for 30 
min at room temperature, embryos were washed three times in rinse solution (0.005% 
Nonidet P-40 and 0.01% sodium deoxycholate in PBS) and then stained in 5 mM potassium 
ferricyanide, 2 mM MgCl2, 0.4%β-gal (5-Bromo-4-chloro-3-indolyl β-D-galactopyranoside, 
B4252 Sigma Aldrich) in PBS for 2–3 h at room temperature followed by 2 times rinse in 
PBS and post-fixation in 3.7% formaldehyde. Frozen 20 µm sections were mounted on 
slides and fixed in 0.2% glutaraldehyde in PBS for 10 min on ice. Slides were incubated in 
detergent rinse solution for 10 min, then stained in β-gal staining solution at 37 °C for 2–3 h 
and post-fixed in 3.7% PFA for 2 h. Slides were counterstained with Nuclear Fast Red and 
Eosin solution.
BrdU and TUNEL labeling experiments
Cell proliferation and apoptosis were assessed using BrdU (Zymed®BrdU Staining kit, 
Invitrogen) and TUNEL (In Situ cell Detection Kit, Fluorescein, Roche-Applied Science) 
kits. The experiments were performed according to manufacturer’s protocols with paraffin 
or frozen 5 µm sections of skin tissue samples. For BrdU or TUNEL double-labeling, 
sections were stained with CD31 (BD Pharmingen) or α-SMA antibodies (abcam), followed 
by BrdU or TUNEL staining.
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Collagen isolation
Dorsal skin tissue samples were collected from 7 week- and 3 month-old Antxr1−/− mice 
and control littermates. After brief wash in sterile DPBS (Gibco Life Technologies) tissue 
samples were immerged in 0.1 M acetic acid for 2 h. After digestion in 0.5 M acetic acid/0.5 
mg/ml pepsin solution for 2 days, samples were dialyzed against 0.1 M acetic acid for one 
day, against 0.1 M NaOH for another day and against Tris-buffer, pH = 7.4, for one more 
day. All steps were done at 4 °C. Bradford assay was used to determine collagen 
concentration (mg of collagen/g tissue).
Mass spectrometry
Pepsin-soluble collagen was extracted from the dorsal skin of mutant and control littermates. 
Following PAGE, the 5% gel was stained with 0.0.5% of R-250 solution in 7.5% 
methanol/10% acetic acid, followed by destaining of gel to a clear background. Excised gel 
band(s) were placed in a microcentrifuge tube with 50 µl of water (Millipore Water) and 
used for LC/MS/MS analysis. Average max intensity (In) of α1(I) and α2(I) protein bands 
were used to estimate the relative amount of collagen type I. The following formula was 
used to calculate relative α1(I)/α2(I) (In):
where X is the intensity of albumin that was used as an internal reference, KO denotes null, 
and WT is the wild type.
Electron microscopy
For histological analysis dorsal skin tissue of mutant and wild-type littermates was fixed in 
2.5% glutaraldehyde and 1.25% paraformaldehyde in 0.1 M cacodylate buffer (pH 7.4) for 
one day. After postfixation in 4% osmium tetroxide, and dehydration steps, the skin tissue 
was embedded in TABB epon (Marivac Ltd., Halifax, Canada). Ultrathin sections were 
contrasted with uranyl acetate and lead citrate before evaluation in a 1200EX JEOL electron 
microscope.
Isolation of primary mouse embryonic fibroblasts
Dissected skin from E17.5 embryos was placed in sterile DPBS (Gibco® Life Technologies) 
supplemented with 1% penicillin and streptomycin (P/S, Gibco® Life Technologies). 
Minced tissue was transferred into 50 ml tubes containing 5 ml of 1 mg/ml collagenase type 
II (17101-015 Gibco® Life Technologies) in serum free DMEM (Gibco® Life 
Technologies) medium and 1% P/S. After incubation in a water-bath shaker for 1 h at 37 °C, 
5 ml of trypsin solution was added for the last 10 min of incubation. Trypsin and collagenase 
activities were quenched by adding 15% FBS (Gibco® Life Technologies). Tissue was 
broken up by pipetting up and down, passed through 40 µm pore size nylon mesh strainer 
(BD Falcon) in new tubes, and tubes were centrifuged for 5 min at 300 g at 4 °C. Cell pellets 
were washed 3 times by centrifugation with DPBS to remove any residual amount of 
collagenase and trypsin, resuspended in DMEM supplemented with P/S, 1% GlutaMax 
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(Gibco® Life Technologies) and 15% FBS and evenly plated on gelatin (attachment factor 
protein, AF, Gibco ® Life Technologies) coated plates. Cells were allowed to grow to 
confluence and either harvested via trypsinization and frozen for storage or split for 
experiments. For consistency, passage 3 (P3) cells were used in all the described 
experiments.
Isolation of primary endothelial cells and fibroblasts from adult mice
Anesthetized mice were perfused with PBS, pH 7.4, to wash out erythrocytes. Dorsal skin 
tissue samples of 7 week-old mutant and wild type littermates were digested in 1 mg/ml 
collagenase type II (17101-015 Gibco® Life Technologies) in DMEM or EGM-2 (Gibco® 
Life Technologies) serum-free medium and P/S solution for isolation of fibroblasts or 
endothelial cells. Fibroblasts were cultured as described above. Dynabeads containing 
M-450 sheep anti-rat IgG (Life Technologies), in PBS + 0.1% BSA + 0.02% NaN3 were 
used to isolate endothelial cells according to manufacturer’s instructions. Purified rat anti-
mouse CD31 (Pharmingen, #553369), was used to prepare anti-mouse CD31-conjugated 
Dynabeads by adding 5 µl of anti-CD31 antibody for each 100 µl of beads and incubation 
overnight at 4 °C.
To isolate CD31+ cells, 30 µl of anti-mouse CD31-coupled Dynabeads was added per 1 ml 
of cell suspension followed by incubation on a rotator for 1 h at room temperature, followed 
by separation on a magnetic separator for 1–2 min. The bound CD31+ cells (beads + cells) 
were cultured in EGM-2 medium, supplemented with growth factors (Lonza) and 20% FBS 
while the unbound fractions, CD31− supernatants, were centrifuged for 5 min at 1200 rpm 
and then resuspended in DMEM medium with 1% of GlutaMax and 15% FBS. CD31-
positive and CD31-negative cells were plated in gelatin-coated plates.
Analysis of rate of collagen synthesis
Isolated E17.5 skin fibroblasts from control and mutant mice were plated in 6-well plates at 
5 × 105 cells/well density in DMEM (Gibco® Life Technologies) medium supplemented 
with 1% penicillin and streptomycin and 15% FBS (Gibco® Life Technologies). Upon 
reaching confluence cells were starved in serum-free medium. After starvation for 24 h, 
medium was replaced by freshly prepared serum-free DMEM medium containing all non-
essential amino acids, except proline (Gibco® Life Technologies); 50 µg/ml of ascorbic acid 
(Sigma Aldrich) was added to support prolyl hydroxylation and collagen synthesis. To 
examine the rate of collagen synthesis, cells were pulse-labeled for 6 h in medium 
containing 1 µCi/ml of L-[14C(U)]-Proline, (50 µCi Perkin Elmer). At the end of the pulse, 
medium was replaced by regular serum-free medium containing all non-essential amino 
acids, including proline. Cells and medium were collected at 3 different time points: right 
after the L-[14C(U)]-Proline pulse and 24 and 36 h after the L-[14C(U)]-Prolinelabeling. 
Collected samples were kept on ice and proteinase inhibitor cocktail (Roche Applied 
Science) was added immediately to the collected media. Cells were resuspended in lysis 
buffer (0.4 M NaCl; 0.1 M Tris–HCl; pH = 7.8 and 1% Triton X-100). After incubation on 
ice for 3 h, cells were spun in a pre-cooled (4 °C) centrifuge at 1000 rpm for 15 min. 
Collagenous proteins in supernatants and collected media were precipitated in 30% 
ammonium sulfate (176 mg (NH4)2SO4 were added to each ml of collected supernatant/
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medium) by centrifugation at 30,000 rpm for 30 min at 4 °C [51]. Precipitates were 
dissolved in Tris–HCl buffer (0.4 M NaCl and 0.1 M Tris–HCl buffer, pH = 7.8) in a 
volume corresponding to 1/50 of initial medium or cell lysate volume. Scintillation fluid was 
added and samples were mixed vigorously. Incorporation of L-[14C(U)]-Proline was 
counted in a scintillation counter and rate of collagen synthesis was expressed as DPM L-
[14C(U)]-Proline/mg of protein. Blank counts, i.e. DPM of dissolving solution and 
scintillation fluid, were subtracted from all samples. Two independent experiments 
(fibroblasts isolated from the skin of E17.5 embryos of 2 controls and 2 knock-outs) were 
performed in triplicates for each time point.
Generation of stable shTem8 cell lines
Human Dermal Microvascular Endothelial Cells (HDMECs) were used to generate stable 
lines with Antxr1 gene knockdown. The cells were treated with TEM8 shRNA Lentiviral 
Particles (sc-44144 V-V, Santa Cruz), Control shRNA Lentiviral Particles (sc-108080, Santa 
Cruz), or copGFP Control Lentiviral Particles (sc-108084, Santa Cruz) in the presence of 5 
µg/ml Polybrene (sc-134220, Santa Cruz). To select stable clones expressing shRNA, cells 
were treated with 2 µg/ml puromycin dihydrochloride (sc-108071, Santa Cruz) until resistant 
colonies were identified and used for subsequent experiments.
Co-culture of fibroblasts and endothelial cells
Primary endothelial cells isolated from skin or stable endothelial cell lines with Antxr1 gene 
knockdown were used for co-culture with primary fibroblasts in a 2:1 ratio.
To examine paracrine signaling between fibroblasts and endothelial cells, endothelial cells 
or fibroblasts were incubated in fibroblast- or endothelial-conditioned medium, respectively. 
To prepare conditioned media (CM), confluent cells were washed 3 times with PBS, then 
starved in corresponding serum-free medium for 24 h followed by centrifugation of 
collected media at 5000 rpm for 10 min and filtration through a 0.45 µm filter to remove cell 
debris. Freshly prepared CM was used in 1:1 ratio with corresponding complete medium to 
incubate cells for additional 48 h. Western blotting, RT-PCR, and gelatin zymography were 
performed after 48 h of cell culturing.
Statistical analysis
Data were analyzed using unpaired 2-tailed Student’s t-test. All results were expressed as 
mean ± standard deviation (data from ≥3 independent experiments). Results were considered 
significant at P ≤ 0.05.
Study approval of animal use
The described animal experiments were done according to the basic protocols approved by 
the Harvard Medical Area Standing Committee and in an agreement with the U.S. Public 
Health Service Policy on Human Care and Use of Laboratory Animals.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Phenotypic characteristics of control and mutant mice. (a) Antxr1 mutants and control 
littermates at E13.5, stained for LacZ activity. Scale bars 1 mm. (b) Antxr1−/− embryos at 
E11.5 show evidence of hemorrhage. Liver is indicated by L. Scale bars 1 mm. (c) At birth 
(P0.5) pups are slightly smaller than wild-type littermates (top). With age (7w(eeks)) 
mutants show growth retardation and shortened skull with frontal bossing (middle and 
bottom). (d) Bar graphs showing weight of control and mutant mice at different postnatal 
ages (n = 10; *P < 0.05, **P < 0.005). (e) Heterozygous knock-in mutant (KI/+) compared 
with control (+/+) at 5 weeks.
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Fig. 2. 
Proliferative and leaky cutaneous blood vessels in mutant mice. (a) Strong LacZ staining in 
cutaneous vessels (20 µm skin sections) of mutant (bottom) compared with control mouse 
(top) at 7 weeks. Scale bars 100 µm. (b) Immunofluorescence showing extravasation (white 
stars) of FITC-coupled dextran in skin section of mutant mouse (bottom) compared with 
control (top). Scale bars 50 µm. (c) Top: Double staining with lectin (green) and antibodies 
against α-SMA (red); white star at erythrocytes escaping through mutant vessel wall. 
Bottom: Double immunostaining for endothelial CD31 (red) and perivascular calponin 
(green) cell markers. White arrows indicate sites of detachment of perivascular cells from 
vessel wall. Scale bars 25 µm. (d) Bar graphs showing BrdU- and TUNEL-labeling data (n = 
10; *P < 0.05). (For interpretation of the references to color in this figure legend, the reader 
is referred to the web version of this article.)
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Fig. 3. 
Cell signaling changes in skin of mutant mice. (a) Real-time PCR shows reduced transcript 
levels for Vegfr1 and Itgb1 (left) and 3-fold increase in Vegfa transcripts (middle) in mutant 
skin extracts; ELISA shows 2-fold increase in VEGF plasma levels (right) in mutant mice (n 
= 6; *P < 0.05). (b) Western blots of skin extracts show changes indicative of increased 
VEGFR2- and Tie2-dependent signaling in mutant mice. (c) Immunohistochemistry of skin 
sections for phospho-p44/42 MAPK (Erk1/2) shows staining of more cells in mutant mice. 
Vascular structures indicated by stippled lines in bottom panels. Red arrows indicate mitotic 
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cells. Scale bars 50 µm (top panels) and 25 µm (bottom panels). (d) Real-time PCR shows 
increased levels of Cxcl12 and Cxcr4 transcripts (left) and ELISA shows increased protein 
levels of CXCL12 (middle) in mutant skin extracts; ELISA also shows increased CXCL12 
levels in plasma (right) of Antxr1−/−mice (n = 6; *P < 0.05). (e) Real-time PCR shows 
increased levels of Vegfa (left), Cxcl12 and Cxcr4 (middle) and ELISA shows increased 
CXCL12 protein levels (right) in skin extracts of Antxr1 KI/+ mice compared with controls 
(n = 6; *P < 0.05). (For interpretation of the references to color in this figure legend, the 
reader is referred to the web version of this article.)
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Fig. 4. 
Extracellular matrix changes in mutant mice. (a) Increased transcript levels for Col1a1 and 
several collagen VI genes, but reduced levels for Col4a1, Col18a1 and Lama5 in skin 
extracts of Antxr1−/− mice (n = 6; *P < 0.05, **P < 0.005). (b) Histology (top) and 
immunohistochemistry (bottom) of skin sections show increased collagen deposition and 
increased levels of α1(I) collagen chains (red) in mutant mice. Scale bars 50 µm. (c) 
Immunohistochemistry shows increased deposition of collagen VI (green) in mutant skin. 
Scale bars 50 µm. (d) Electron microscopy indicates loss of vascular basement membranes 
in mutant mice. Perivascular space indicated by P. Scale bars 500 nm. (e) Left: 
Radiolabeling with L-[14C(U)]-Proline of collagen synthesized by fibroblasts isolated from 
control and mutant embryos shows increased incorporation in mutant culture medium and 
cell layer. Right: Differences between incorporation into collagenous protein at 6 h of 
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incubation (n = 6; *P < 0.05, **P < 0.005). (f) Increased amounts of pepsin-resistant 
collagen in skin extracts of mutant mice at 7 weeks and 3 months (n = 4; *P < 0.05, **P < 
0.005). (For interpretation of the references to color in this figure legend, the reader is 
referred to the web version of this article.)
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Fig. 5. 
Inflammatory cells in mutant skin. (a) Histology of skin sections from control (Antxr1fl/fl 
and Antxr1+/+::Cdh5Cre) and homozygous (Antxr1fl/fl::Cdh5Cre) conditional knock-out 
mice (left and middle; scale bar 200 µm); right: immunohistochemical staining for collagens 
VI (scale bar 100 µm and I (scale bar 200 µm). (b) Increased levels of transcripts for Col6a1 
(left, black bars) and Col1a1 (right, gray bars) in Antx1fl/fl::Cdh5Cre mutant skin (n=4; * P 
< 0.05). (c) Increased numbers F4/80-positive cells (green) in mutant skin. Scale bar 50 µm. 
(n=9; * P < 0.05). (d) Increased numbers of mast cells in mutant skin. Scale bar 200 µm. 
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(n=10; * P < 0.05). (e) Immunohistochemical staining of skin sections for FSP1 
demonstrates higher expression in cutaneous vascular regions of Antxr−/− mice. Arrows 
indicate FSP1-positive cells associated with vessels. Scale bars 50 µm.
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Fig. 6. 
MMP changes in skin of mutant animals. (a) Transcript levels of Mmp2 and Mmp9 were not 
affected by loss of Antxr1 (n ≥ 4). (b) Increased protein levels of MMP9 and MMP2 in skin 
extracts of Antxr1−/− mice. (c) Reduced activity of MMP2 in Antxr1−/− mice (top) by 
gelatin zymography, and increased mature/cleaved form of MMP14 in mutant skin by 
western blotting (bottom). (d) Reduced MMP2 activity in skin extracts from Timp2−/− and 
Antxr1fl/fl::Cdh5Cre (flfl::Cre) mice when compared with WT (+/+), Antxr1fl/fl (fl/fl) or 
Cdh5Cre (Cre) control mice, but not to the extent seen in Antxr1−/− (−/−) mice (n ≥ 3; *P < 
0.05, **P < 0.005). Representative zymography raw data on which this figure is based are 
shown in Supplemental Fig. 5a. (e) Reduced transcript levels of Timp2 and Timp3 in skin 
extracts from Antxr1−/− animals (n = 4; *P < 0.05).
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Fig. 7. 
Dysregulation of MMP2 activity in TEM8 mutant cells. (a) ELISA showing VEGF levels in 
lysates of stable endothelial cell lines with different degrees of Antxr1 knockdown 
(shTEM8-1/26%; shTEM8-2/60%; shTEM8-3/90%). (n = 3; *P < 0.05). (b) MMP2 activity 
in lysates of stable endothelial lines with different degrees of Antxr1 knockdown. (n = 3; *P 
< 0.05). (c) MMP2 activity is not affected when endothelial Antxr1 knock-down cells are co-
cultured with WT fibroblasts, but is dramatically reduced when the co-cultures contain 
fibroblasts isolated from Antxr1−/− mice. (n ≥ 3; *P < 0.05, **P < 0.005) (d) Left: MMP2 
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activity in lysates of primary endothelial (CD31-positive) cells from Antxr1+/+ and 
Antxr1−/− mice co-cultured with Antxr1+/+ or Antxr1−/− fibroblasts (FB) or exposed to 
conditioned medium (FCM) from such fibroblasts. Right: MMP2 activity in lysates of 
primary fibroblasts (CD31-negative) from Antxr1+/+ and Antxr1−/− mice cultured with 
conditioned medium (ECM) from Antxr1+/+ or Antxr1−/− primary endothelial cells. (n = 3; 
*P < 0.05, **P < 0.005).
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